18 Nov 2025 | 5 Mins Read
Supriya Lifescience target of Rs 850: Deven Choksey
Flipitmoney
Supriya Lifescience's revenue grew 37.7% QoQ and 20.3% YoY to INR 1,998 Mn, surpassing estimates and marking a recovery from a muted Q1. The improvement was driven by operational normalization and ramp-up of the Module E facility, with broad-based growth across various product segments, and exports contributing 81% of quarterly revenues and 24.0x Sept'27 EPS implies target price INR 850.